Clinical Trial Update: An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease [Phase 1]

View source ↗

Summary

Phase 1 exploratory trial of AVI-4020 in patients with possible acute neuroinvasive West Nile virus disease has been terminated. The study involved Sarepta Ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• West Nile Fever
• West Nile Neuroinvasive Disease
• West Nile Virus Infection

Drugs mentioned

• AVI-4020 (AVI-4020)

Snippet

Sponsor: Sarepta Therapeutics, Inc. | Conditions: West Nile Fever | Phase 1 | Status: TERMINATED